Evaluation of Genetic Polymorphisms of HOTTIP (rs5883064, rs1859168, rs2067087) in Patients with Non-Hodgkin Lymphoma and Comparison with Healthy Subjects

对非霍奇金淋巴瘤患者 HOTTIP 基因多态性(rs5883064、rs1859168、rs2067087)的评估及与健康受试者的比较

阅读:1

Abstract

BACKGROUND: Non-Hodgkin Lymphoma (NHL) is a group of blood cancers in which lymphoid cells develop abnormal growth due to genetic changes or other factors without Reed-Sternberg cells. Given the proven role of HOTTIP gene polymorphisms in the prognosis, diagnosis, and treatment of different kinds of carcinomas, this study investigated the association between rs5883064, rs1859168, and rs2067087 polymorphisms of the gene with NHL susceptibility in a population of Zahedan. MATERIALS AND METHODS: A total of 190 NHL cases (122 males and 68 females), aged 44.45±15.29 years, and 190 healthy individuals (107 males and 83 females, 43.13±12.15 years) were collected as study subjects. The gene polymorphisms were examined by PCR RFLP and ARMS methods. RESULTS: Our results showed that the rs5883064 Del>Ins polymorphism of the HOTTIP gene has a protective role and significantly reduces the risk of lymphoma. The 1859168 C>A variant in the co-dominant model is a risk criterion for non-Hodgkin lymphoma and significantly increases this disease's risk. The HOTTIP rs2067087 G>C variant had a protective role and significantly reduced the risk of lymphoma. CONCLUSION: Our results showed that the association between HOTTIP gene polymorphisms and NHL incidence has a significant pattern. More studies in larger populations and various ethnicities are recommended to confirm our findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。